ArrowMark Colorado Holdings’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.9M Sell
469,831
-94,238
-17% -$3.97M 0.85% 19
2026
Q2
$26.5M Sell
564,069
-1,030,648
-65% -$25.5M 1.1% 10
2026
Q1
$30.1M Buy
+1,594,717
New +$27.1M 0.8% 40

Other funds holding DFTX

ArrowMark Colorado Holdings's DFTX Position: Q3 2026 in Review

ArrowMark Colorado Holdings reduced its Definium Therapeutics (DFTX) stake by 17% in Q3 2026, selling an estimated $3.97M and leaving 469,831 shares worth $17.9M. The position accounts for 0.85% of the portfolio, ranked #19.

ArrowMark Colorado Holdings first reported a position in DFTX in Q1 2026 and has held it in 3 quarters since. The position peaked at $30.1M in Q1 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • ArrowMark Colorado Holdings held 469,831 shares of Definium Therapeutics worth $17.9M as of Q3 2026.
  • ArrowMark Colorado Holdings sold 94,238 Definium Therapeutics shares in Q3 2026, an estimated $3.97M.
  • Definium Therapeutics made up 0.85% of ArrowMark Colorado Holdings's portfolio in Q3 2026, its #19 holding.
  • ArrowMark Colorado Holdings first reported a position in Definium Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • ArrowMark Colorado Holdings's Definium Therapeutics position peaked at $30.1M in Q1 2026.
  • 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.